pembrolizumab
merck
['lba6', 'melanoma', 'pembro']
#esmo22 presidential symposium ii highlights: s1801 (lba6; sapna patel) - neoadjuvant vs adjuvant pembrolizumab in resectable stage iii-iv melanoma (n=313) study met primary endpoint! significant efs improvement with neoadjuvant vs adjuvant pembro. 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge